Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Schizophrenia Spectrum and Other Psychotic Disorders

• A Randomized Controlled Trial With Rituximab - for Schizophrenia Spectrum Disorder in Adults
• Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
• Rituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019)
• Insight Enhancement Program vs. Metacognitive Training for Psychosis in Patients With Schizophrenia: A Three-Armed Comparative Randomized Controlled Trial
• Mindfulness-based Social Cognition Training for Psychosis (SocialMind): A Feasibility Study
• Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia
• Effectiveness of a Mindfulness-based Group Training Addressing Social Cognition in First Episode Psychosis (AGES-Mind)
• Berberine as Adjuvant Treatment for Schizophrenia Patients
• The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms
• Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
• Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of Schizophrenia
• Investigator Initiated Study - Asenapine Early Psychosis
• One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome
• Specialized Treatment Early in Psychosis (STEP)
• Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia
• Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia